May 24 marks World Schizophrenia Day, a moment to recognize the profound impact of schizophrenia on individuals, carers, and communities. Severe mental illness can threaten the very essence of who we are, reshaping lives in ways that are not always seen or fully understood by others. Could more be done? Read the new POLITICO Europe article, supported and funded by Teva, which draws on recent patient and carer insights to explore why change in schizophrenia care is critically needed: https://ow.ly/4HSP50Z2yus At Teva, we are committed to advancing innovation in neuroscience, addressing unmet needs, delivering with scale, speed and precision. #WorldSchizophreniaDay #TevaNeuroscience #Stigma
Teva Pharmaceuticals’ Post
More from this author
Explore content categories
- Career
- Productivity
- Finance
- Soft Skills & Emotional Intelligence
- Project Management
- Education
- Technology
- Leadership
- Ecommerce
- User Experience
- Recruitment & HR
- Customer Experience
- Real Estate
- Marketing
- Sales
- Retail & Merchandising
- Science
- Supply Chain Management
- Future Of Work
- Consulting
- Writing
- Economics
- Artificial Intelligence
- Employee Experience
- Workplace Trends
- Fundraising
- Networking
- Corporate Social Responsibility
- Negotiation
- Communication
- Engineering
- Hospitality & Tourism
- Business Strategy
- Change Management
- Organizational Culture
- Design
- Innovation
- Event Planning
- Training & Development
The “Trieste model” of critical psychiatry has gradually flattened into a hegemonic, medicalized approach. Long-acting treatments are presented as a form of “ghost therapy,” supposedly meant to create space for dialogue and other interventions; more often, however, they end up serving as a way to forget the patient. What is needed is simply a return to Basaglia’s insights: a partial decolonization of the rigid ideal that has become fossilized, while remembering that everything was already — even back then, in the mythical year of 1978 — One (Mental) Health.